1-4 of 4
Farrukh Naveed, BSc
Close
Sort by
Journal Articles

High Busulfan Exposure Is Associated with Worse Outcome in a Daily IV Busulfan and Fludarabine Transplant Regimen.

Michelle Geddes, MD, Shahbal B. Kangarloo, PhD, Farrukh Naveed, BSc, Quinlan M. Diana, RN, Ahsan Chaudhry, MD, Mary Lynn Savoie, MD, Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Christopher Brown, MD, PhD, Jan Storek, MD, PhD, Borje Andersson, MD, PhD, James A. Russell, MA, MB, B. Chir
Journal: Blood
Blood (2006) 108 (11): 313.
https://doi.org/10.1182/blood.V108.11.313.313
Published: 2006
Journal Articles

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

Farrukh Naveed, BSc, Shahbal Kangarloo, BSc, MSc, Ahsan Chaudhry, BSc, MD, Michelle Geddes, BSc, MD, Diana Quinlan, RN, BN, CCRP, James Russell, MA, MB, BChir, FRCPE
Journal: Blood
Blood (2006) 108 (11): 2941.
https://doi.org/10.1182/blood.V108.11.2941.2941
Published: 2006
Journal Articles

Once Daily IV Busulfan Given with Fludarabine in Allogeneic Stem Cell Transplantation Conditioning: High vs Low Busulfan AUC Does Not Alter Toxicities or Transplant Outcome.

Michelle Geddes, MD, Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Ahsan M. Chaudhry, MD, Oluyemi Jeje, MD, Mary L. Savoie, MD, Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Christopher Brown, MD, Jan Storek, MD, PhD, Diana Quinlan, RN, Borje Andersson, MD, James A. Russell, MBBChir
Journal: Blood
Blood (2005) 106 (11): 1763.
https://doi.org/10.1182/blood.V106.11.1763.1763
Published: 2005
Journal Articles

Individualized Once-Daily Dosing of Intravenous Busulfan: A Pharmacokinetic Study in Patients Undergoing Conditioning for Allogeneic Stem Cell Transplantation.

Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Borje S. Andersson, MD, PhD, Diana Quinlan, BN, James A. Russell, FRCP
Journal: Blood
Blood (2004) 104 (11): 98.
https://doi.org/10.1182/blood.V104.11.98.98
Published: 2004